首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Multiple sclerosis and related disorders

缩写:MULT SCLER RELAT DIS

ISSN:2211-0348

e-ISSN:2211-0356

IF/分区:3.0/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引5415
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Wei Liu,Penju Liu,Qinpeng Wang et al. Wei Liu et al.
Multiple sclerosis (MS) is a chronic central nervous system disorder characterized by immune-mediated inflammation and demyelination. Although East Asia was historically regarded as a low-prevalence region, recent evidence suggests a rising...
Said Alizada,Asiye Tuba Özdoğar,Irem Kara et al. Said Alizada et al.
Background: Pain is a common and disabling symptom in multiple sclerosis (MS) and may arise from different mechanisms. Among pain subtypes, neuropathic pain (NP) and musculoskeletal pain (MSP) are the most frequent, yet t...
Shichun Li,Haiyan Yao,Ting Li et al. Shichun Li et al.
Background: Satralizumab is effective for relapse prevention in AQP4-positive neuromyelitis optica spectrum disorder (NMOSD), but its safety during pregnancy has not been established. While several cases have reported con...
Ruth Ann Marrie,Chiara Gottheil,Afolasade Fakolade et al. Ruth Ann Marrie et al.
Background: We lack an understanding of the diversity characteristics of people with multiple sclerosis (MS) in Canada; most studies report only age and sex. We conducted a national survey to better understand the diversi...
An-Ning Wang,Li-Xin Wang,Qing Yang et al. An-Ning Wang et al.
Background: Neuromyelitis Optica Spectrum Disease (NMOSD) is a highly disabling autoimmune disease. Many patients engage in social withdrawal due to disease-related concerns and physical limitations, leading to widespread...
G Cabañas Engenios,N Mena García,P Garay Albízuri et al. G Cabañas Engenios et al.
Introduction: The long-term benefit-risk balance of disease-modifying therapies (DMTs) in multiple sclerosis (MS) becomes increasingly relevant with ageing and prolonged disease stability. Discontinuation of DMTs has been...
Valerio Nicolella,Carmela Polito,Vincenzo Criscuolo et al. Valerio Nicolella et al.
Background: Plasma neurofilament light chain (pNfL) is an established biomarker of neuroaxonal injury in multiple sclerosis (MS), but analytical variability across platforms may limit clinical comparability. ...
Olga Vampertzi,Theofanis Vavilis,Androula Zelilidou et al. Olga Vampertzi et al.
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a distinct immune-mediated demyelinating central nervous system disorder, frequently presenting as optic neuritis in children and adolescents. Conversely, aquaporin-...
Maiara Laís Mallmann Kieling Peres,Natalia Schuh,Vanessa Brzoskowski Dos Santos et al. Maiara Laís Mallmann Kieling Peres et al.
Objective: To investigate the relationship between patient-reported speech difficulties, clinician-rated dysarthria severity, and acoustic speech measures in persons with multiple sclerosis (MS). ...